Literature DB >> 9924005

Use of the Caco-2 cell model to assess the relative lead-chelating ability of diasterioisomers of 2,3-dimercaptosuccinic acid.

E A Pigman1, J R Lott, Q Fernando, J Blanchard.   

Abstract

The purpose of this study was to examine the mechanisms of lead (Pb) uptake by human intestinal cells and to compare the intestinal transport and relative lead-chelating ability of two diastereoisomeric forms (i.e., meso and racemic) of 2, 3-dimercaptosuccinic acid (DMSA). The model used was the human adenocarcinoma (Caco-2) cell monolayer. The Caco-2 cells were cultured in flasks for examination of cellular uptake of lead and subsequent chelation of the lead by the DMSA isomers. For assessment of the comparative intestinal transport of the diastereoisomers, the Caco-2 cells were cultured on semipermeable supports. The effects of N-ethylmaleimide and 1,25-dihydroxyvitamin D3 (vitamin D3) on the uptake of lead by the Caco-2 monolayer were examined to determine the contributions of sulfhydryl-binding and calcium-binding protein, respectively, to the lead uptake process. Analysis of lead was performed using both macro- and micro-proton-induced X-ray emission (PIXE), and DMSA was measured spectrophotometrically following derivatization with 5,5'-dithiobis-2-nitrobenzoic acid. Results from micro-PIXE imaging suggest that lead is bound on the surface of the cell, and that sulfhydryl binding may be an important step in the uptake of lead by the Caco-2 cells. Macro-PIXE results indicate that the racemic form of DMSA may be more effective in chelating lead from within the cell. Comparison of the transport of the two DMSA diastereoisomers indicates that the racemic form is transported across the Caco-2 monolayer more readily than the meso form.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9924005      PMCID: PMC1566335          DOI: 10.1289/ehp.99107111

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  19 in total

Review 1.  Intestinal interactions of lead and calcium.

Authors:  C S Fullmer
Journal:  Neurotoxicology       Date:  1992       Impact factor: 4.294

2.  Lead and child development.

Authors:  J M Davis; D J Svendsgaard
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

3.  [Comparative efficacy of antidotal activity of spatial isomers of dimercaptosuccinic acid in mercury poisoning].

Authors:  I E Okonishnikova
Journal:  Gig Tr Prof Zabol       Date:  1970-08

4.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 5.  meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.

Authors:  H V Aposhian; M M Aposhian
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

6.  Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.

Authors:  R M Maiorino; J M Akins; K Blaha; D E Carter; H V Aposhian
Journal:  J Pharmacol Exp Ther       Date:  1990-08       Impact factor: 4.030

7.  Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.

Authors:  H V Aposhian; R M Maiorino; R C Dart; D F Perry
Journal:  Clin Pharmacol Ther       Date:  1989-05       Impact factor: 6.875

8.  Stereoisomeric selectivity of 2,3-dimercaptosuccinic acids in chelation therapy for lead poisoning.

Authors:  X Fang; Q Fernando
Journal:  Chem Res Toxicol       Date:  1995-06       Impact factor: 3.739

9.  Vitamin D-dependent active calcium transport: the role of CaBP.

Authors:  F Bronner
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

10.  Vitamin D-regulated calcium transport in Caco-2 cells: unique in vitro model.

Authors:  A R Giuliano; R J Wood
Journal:  Am J Physiol       Date:  1991-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.